ERBB2 and breast carcinoma: In conclusion, a greater proportion of patients who receive NCT might be able to avoid ALND, which could result in the removal of fewer LNs with lower LN positivity as well as a higher pCR achievement rate, compared to those who receive NET, especially among young women with ER-positive/HER2-negative and LN+ breast cancer.